US Patent Issued to Merck Sharp & Dohme on Oct. 7 for "Oxazolidinone compound and methods of use thereof as an antibacterial agent" (American, Chinese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,435,077, issued on Oct. 7, was assigned to Merck Sharp & Dohme LLC (Rahway, N.J.).

"Oxazolidinone compound and methods of use thereof as an antibacterial agent" was invented by Brendan M. Crowley (Collegeville, Pa.), Philippe Nantermet (Lansdale, Pa.), David B. Olsen (Lansdale, Pa.), Takao Suzuki (Shanghai), Lihu Yang (Edison, N.J.) and Lanying You (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the oxazolidinone compound of Formula (I): and pharmaceutically acceptable salts thereof. The present invention also relates to compositions containing the compound of Formula (I). The invention also provides methods for ...